1. Non-alcoholic fatty liver disease (NAFLD) model in cynomolgus monkeys;

2. Cynomolgus monkey liver fibrosis model (HF model, branch);

3. Pharmacodynamic test of normal monkey glucose tolerance model;

4. STZ induced diabetes model in cynomolgus monkeys or rhesus;

5. A diabetic model spontaneously produced by cynomolgus monkeys or rhesus;

6. Obese and diabetic rats and mice models;

7. Nonalcoholic fatty liver model (NAFLD, NAFL, NASH);

8. Osteoporosis model;

9. Renal failure model;

10. Dyslipidemia model;

11. Rodent model of spontaneous or induced obesity.